BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In the CML LSCs from patients, the IFN-γ response signature was the highest in the most primitive CD34 + CD38- cells with low BCR-ABL1 activity (clusters 2, and 5) (Fig. 4g).